last fundraise of $13m at 1.6p per share created 46% extra shares, I wonder what size the fund raise will be that they warned in the financial report would happen H2 2020. Gotta place a lot of shares at 0.8p to fund the DFS or the actual project, maybe 80% extra shares
Total of nearly 600 samples https://www.quotientbd.com/news/quotient-limited-announces-sars-cov-2-covid-19-antibody-test-final-performance-data
What impact will the tie up of open orphan offering Quotients antibody test in UK, testing starts in next few weeks, test has 100% sensitivity (ability to detect COVID-19 antibodies) and 99.8% specificity (ability to rule out the presence of COVID-19 antibodies).
Quotient have other distributors in other markets too
This is from Mercola a very unreliable source https://quackwatch.org/11Ind/mercola/
Listen to about 11 mins in. Talk of spinning off imutex stake as separate listed company with existing shareholders getting one for one shares
https://m.soundcloud.com/doc-h-4/6-5-20-interview-cathal-friel
The first study is ready to publish data which has been passed hence the announcement of the lancet paper https://clinicaltrials.gov/ct2/show/results/NCT03055000
The second study is on-going until 2021 https://clinicaltrials.gov/ct2/show/results/NCT04009824
Why was this interview taken down? Also made private on YouTube, what did they let slip?
https://www.proactiveinvestors.co.uk/companies/news/908750/open-orphan-plc-s-cathal-friel-details-merger-with--sleeping-giant--hvivo-908750.html
Why was this interview taken down? Also made private on YouTube, what did they let slip?
https://www.proactiveinvestors.co.uk/companies/news/908750/open-orphan-plc-s-cathal-friel-details-merger-with--sleeping-giant--hvivo-908750.html